Oxford, United Kingdom

Kyriacos Andreou Mitrophanous

This inventor holds 20 USPTO granted patents and 7 published patent applications and 13 EPO patents, primarily in Viral Vector Technology. Top assignees: Oxford Biomedica (UK) Limited, Oxford Biomedica, Inc., The University of North Carolina at Chapel Hill. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyriacos Andreou Mitrophanous. Retrieved from https://idiyas.com/inventor/kyriacos-andreou-mitrophanous

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 214(Granted Patents)


Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Retroviral Vector
Viral Vector Production
Catecholamine Enzyme Fusions
Virus Purification
Antiviral Vectors
Vector Delivery
High Titre Vectors
Equine Infectious Anemia Virus
20 patents (USPTO):Explore Patents

Title: Innovations and Achievements of Kyriacos Andreou Mitrophanous

Introduction: Kyriacos Andreou Mitrophanous is a prominent inventor based in Oxford, GB, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 20 patents, he has made noteworthy advancements in the production of retroviral vectors and viral vector production systems.

Latest Patents: Among his latest inventions is a patent for a retroviral vector, which includes a cell designed for producing retroviral vectors. This cell comprises nucleic acid sequences encoding important components, including gag-pol, env, and the RNA genome of the retroviral vector. Notably, at least two nucleic acid sequences are positioned at the same genetic locus and are arranged in reverse and/or alternating orientations. Additionally, his patent on a viral vector production system details a nucleic acid sequence containing a binding site linked to a nucleotide of interest; the binding site interacts with an RNA-binding protein to repress translation in a viral vector production cell.

Career Highlights: Kyriacos has gained valuable experience while working with esteemed companies such as Oxford Biomedica Limited and Oxford Biomedica, Inc. His work has focused on forward-thinking solutions in the biotech sector, further establishing his reputation as a leading inventor.

Collaborations: Throughout his career, Kyriacos has collaborated with notable professionals including Alan John Kingsman and Narry Kim. These collaborative efforts have significantly contributed to the advancement of his research and patented innovations.

Conclusion: Kyriacos Andreou Mitrophanous stands out as an influential inventor in the biotechnology landscape. His cutting-edge patents and collaborations highlight his dedication to advancing the field, making a meaningful impact through his innovative work in retroviral vector technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…